De Windt LJ - Search Results

1

MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.

Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouysségur J, Pagès G, De Windt LJ, Doevendans PA, Molkentin JD. Lips DJ, et al. Among authors: de windt lj. Circulation. 2004 Apr 27;109(16):1938-41. doi: 10.1161/01.CIR.0000127126.73759.23. Epub 2004 Apr 19. Circulation. 2004. PMID: 15096454

2

Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Taigen T, De Windt LJ, Lim HW, Molkentin JD. Taigen T, et al. Among authors: de windt lj. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1196-201. doi: 10.1073/pnas.97.3.1196. Proc Natl Acad Sci U S A. 2000. PMID: 10655507 Free PMC article.

3

Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.

De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW 2nd, Kitsis RN, Molkentin JD. De Windt LJ, et al. Circ Res. 2000 Feb 18;86(3):255-63. doi: 10.1161/01.res.86.3.255. Circ Res. 2000. PMID: 10679475

4

Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.

De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. De Windt LJ, et al. J Biol Chem. 2000 May 5;275(18):13571-9. doi: 10.1074/jbc.275.18.13571. J Biol Chem. 2000. PMID: 10788473 Free article.

5

Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.

Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Lim HW, et al. Among authors: de windt lj. Circulation. 2000 May 23;101(20):2431-7. doi: 10.1161/01.cir.101.20.2431. Circulation. 2000. PMID: 10821822

6

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.

Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD. Bueno OF, et al. Among authors: de windt lj. EMBO J. 2000 Dec 1;19(23):6341-50. doi: 10.1093/emboj/19.23.6341. EMBO J. 2000. PMID: 11101507 Free PMC article.

7

The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo.

Bueno OF, De Windt LJ, Lim HW, Tymitz KM, Witt SA, Kimball TR, Molkentin JD. Bueno OF, et al. Among authors: de windt lj. Circ Res. 2001 Jan 19;88(1):88-96. doi: 10.1161/01.res.88.1.88. Circ Res. 2001. PMID: 11139479

8

Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.

De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, Glascock BJ, Kimball TF, del Monte F, Hajjar RJ, Molkentin JD. De Windt LJ, et al. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3322-7. doi: 10.1073/pnas.031371998. Proc Natl Acad Sci U S A. 2001. PMID: 11248077 Free PMC article.

9

The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.

Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD. Liang Q, et al. Among authors: de windt lj. J Biol Chem. 2001 Aug 10;276(32):30245-53. doi: 10.1074/jbc.M102174200. Epub 2001 May 16. J Biol Chem. 2001. PMID: 11356841 Free article.

10

Estrogenic hormone action in the heart: regulatory network and function.

Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA. Babiker FA, et al. Among authors: de windt lj. Cardiovasc Res. 2002 Feb 15;53(3):709-19. doi: 10.1016/s0008-6363(01)00526-0. Cardiovasc Res. 2002. PMID: 11861041 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters